STRS Ohio’s Cogent Biosciences COGT Stock Holding History

STRS Ohio’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$689K	Sell	17,900 -12,600	-41%	-$465K	﹤0.01%	859
2025 Q4	$1.08M	Sell	30,500 -11,000	-27%	-$309K	﹤0.01%	680
2025 Q3	$596K	Buy	41,500 +35,500	+592%	+$421K	﹤0.01%	939
2025 Q2	$43.1K	Hold	6,000	–	–	﹤0.01%	2049
2025 Q1	$35.9K	Hold	6,000	–	–	﹤0.01%	1803
2024 Q4	$46.8K	Buy	+6,000	New	+$59.8K	﹤0.01%	1737
2021 Q4	–	Sell	-8,600	Closed	-$72K	–	2212
2021 Q3	$72K	Hold	8,600	–	–	﹤0.01%	1996
2021 Q2	$69K	Buy	+8,600	New	+$72.6K	﹤0.01%	2052
2019 Q2	–	Sell	-250	Closed	-$4K	–	2123
2019 Q1	$4K	Hold	250	–	–	﹤0.01%	2026
2018 Q4	$4K	Hold	250	–	–	﹤0.01%	2052
2018 Q3	$10K	Hold	250	–	–	﹤0.01%	2076
2018 Q2	$14K	Buy	+250	New	+$12K	﹤0.01%	2075

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

STRS Ohio's COGT Position: Q1 2026 in Review

STRS Ohio reduced its Cogent Biosciences (COGT) stake by 41% in Q1 2026, selling an estimated $465K and leaving 17,900 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #859.

STRS Ohio first reported a position in COGT in Q2 2018 and has held it in 12 quarters since. The position peaked at $1.08M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

STRS Ohio held 17,900 shares of Cogent Biosciences worth $689K as of Q1 2026.
STRS Ohio sold 12,600 Cogent Biosciences shares in Q1 2026, an estimated $465K.
Cogent Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #859 holding.
STRS Ohio first reported a position in Cogent Biosciences in Q2 2018 and has held it in 12 quarters since.
STRS Ohio's Cogent Biosciences position peaked at $1.08M in Q4 2025.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.